Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05953233 · ClinicalTrials.gov registry record · NA
School Inner City Air Study
A NA study of Viral Infection, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05953233: Recruiting NA study of Viral Infection, sponsored by Massachusetts General Hospital.
NCT05953233 is a NA study of Viral Infection that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 200 participants, roughly in line with the 211-participant average among 11 other Viral Infection trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05953233, a NA study of Viral Infection, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this randomized clinical trial is to test the efficacy of high efficiency particulate air (HEPA) cleaners in reducing respiratory viral exposure and infections in elementary school classrooms. Classrooms will be randomized to active vs. sham HEPA cleaners. The main questions it aims to answer are: * Do classroom HEPA cleaners reduce exposure to viruses? * Do classroom HEPA cleaners reduce student and teacher infections? * Do classroom HEPA cleaners reduce infections in family members?
Primary Outcome
Presence/absence of a respiratory virus in upper respiratory sample
Conditions Studied
Interventions
- OTHER Active classroom HEPA cleaner
- OTHER Sham classroom HEPA cleaner
Study Locations (1)
Massachusetts
- Mass General Brigham - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-09-15 |
| Est. Completion | 2030-08 |
| Phase | NA |
What NCT05953233 shows while recruiting
NCT05953233 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 211-participant average among 11 other Viral Infection trials with a reported enrollment target.
The record links to 1 condition, with Viral Infection appearing as the primary indexed condition, and to 2 interventions - of which Active classroom HEPA cleaner is the first listed.
NCT05953233 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05953233 about?
NCT05953233 is a clinical study titled "School Inner City Air Study". The goal of this randomized clinical trial is to test the efficacy of high efficiency particulate air (HEPA) cleaners in reducing respiratory viral exposure and infections in elementary school classrooms. Classrooms will be randomized to active vs. sham HEPA cleaners. The main questions it aims to a...
What is the current status of trial NCT05953233?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-09-15. Estimated completion is 2030-08.
What conditions does trial NCT05953233 study?
This clinical trial studies the following conditions: Viral Infection.
What interventions are being tested in trial NCT05953233?
The interventions under investigation include: Active classroom HEPA cleaner (OTHER), Sham classroom HEPA cleaner (OTHER).
Who is sponsoring clinical trial NCT05953233?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05953233 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Viral Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05953233's enrollment target sits among peer trials
200 3rd of 11 higher than 7 of 11 other Viral Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Viral Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Mouthrinse on the Microbiome of the Oral Cavity and GI Tract
RECRUITING · NA
-
Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Department (RADIATE)
ACTIVE NOT RECRUITING · NA
-
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
RECRUITING · Phase 1
-
Third Party Viral Specific T-cells (VSTs)
RECRUITING · Phase 2
-
Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis
RECRUITING · Phase 1
-
Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI